TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novus Scientific AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
44,205
|
34,377
|
21,768 |
| Financial expenses |
4,513
|
176
|
85 |
| Earnings before taxes |
3,740
|
7,759
|
-5,939 |
| EBITDA |
14,470
|
6,957
|
-6,426 |
| Total assets |
47,645
|
45,596
|
37,885 |
| Current assets |
45,269
|
43,140
|
34,716 |
| Current liabilities |
34,515
|
33,392
|
33,441 |
| Equity capital |
13,130
|
12,204
|
4,444 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
16
|
16
|
16 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
27.6%
|
26.8%
|
11.7% |
| Turnover per employee |
2,763
|
2,149
|
1,360 |
| Profit as a percentage of turnover |
8.5%
|
22.6%
|
-27.3% |
| Return on assets (ROA) |
17.3%
|
17.4%
|
-15.5% |
| Current ratio |
131.2%
|
129.2%
|
103.8% |
| Return on equity (ROE) |
28.5%
|
63.6%
|
-133.6% |
| Change turnover |
9,828
|
12,609
|
3,862 |
| Change turnover % |
29%
|
58%
|
22% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.